TLSI 8-K: SEC filing
TriSalus Life Sciences
Filed with the SEC on · accession 0001628280-26-072513
TLSI filed a 8-K (current report) with the SEC on Nov 10, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Summary of the filing
TriSalus Life Sciences issued a press release announcing its financial results for the third quarter ended September 30, 2026, furnished under Item 2.02 of Form 8-K.
Key details
✦ Ask GOAX AI about this filing — what it means for TLSI, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TLSI?
Click hereFrequently asked questions
What did TLSI file with the SEC on Nov 10, 2026?
TLSI filed a 8-K (SEC filing). TriSalus Life Sciences issued a press release announcing its financial results for the third quarter ended September 30, 2026, furnished under Item 2.02 of Form 8-K.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other TLSI SEC filings
Get alerts when TLSI files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days